Board of Directors

  • Jon Aisbitt (Chairman)

    Former chairman of Man Group plc.; more than 20 years' experience in international corporate finance and was previously partner and managing director in the Investment Banking Division of Goldman Sachs

  • Biresh Roy (CEO)

  • Dr Richard Garraway (COO)

  • Michael Earl (Non-executive and shareholder director)

    Founder and shareholder of Pro Bono Bio. Former VP European Operations at Chiron and Commercial development at Celltech. Over 30 years in the healthcare industry at Smithkline Beecham, Abbott and Astra Zeneca

  • Ali Baruni (Non-executive Director)

    Over 37 years' experience in the financial services industry; previously held senior roles in Bankers Trust Company and Citibank 

  • Oleg Kiselev (Non-executive Director)

    Deputy chairman of the executive board of Rusnano Management Company LLC.

  • David Quint (Non-executive Director)

    Founder and CEO of RP&C investment banking group.

  • Irina Rapoport (Non-executive Director)

    CEO of Rusnano Capital ; more than 20 years’ experience in management, investment and strategic planning; previously Managing Director of Renaissance Asset Management.

  • Dmitry Volokhov (Non-executive Director)

    Investment director at Rusnano Corporation; more than 10 years' experience in investment, valuation analysis and corporate finance.